Legal Representation
Attorney
Robert L. Powley
USPTO Deadlines
Next Deadline
124 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
November 14, 2025
Extension Available
Until May 14, 2025
Application History
17 eventsDate | Code | Type | Description |
---|---|---|---|
Mar 28, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Mar 27, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED |
Mar 27, 2025 | EXT2 | S | SOU EXTENSION 2 FILED |
Mar 27, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jun 21, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
Jun 21, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
Jun 21, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jun 21, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
May 14, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Mar 19, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Mar 19, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
Feb 28, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Feb 28, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Feb 15, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Feb 14, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Jun 23, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
May 25, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...